Brokerages Set OR Royalties Inc. (NYSE:OR) PT at $38.25

Shares of OR Royalties Inc. (NYSE:OR) have earned a consensus recommendation of “Buy” from the nine brokerages that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $38.25.

OR has been the topic of a number of research reports. Canaccord Genuity Group raised OR Royalties from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 22nd. Zacks Research upgraded shares of OR Royalties from a “hold” rating to a “strong-buy” rating in a report on Wednesday. Wall Street Zen upgraded OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 19th. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of OR Royalties in a research report on Wednesday. Finally, Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price on the stock in a research note on Thursday, November 6th.

OR Royalties Stock Performance

Shares of OR opened at $40.00 on Friday. The firm has a market cap of $7.49 billion, a PE ratio of 50.63 and a beta of 0.76. OR Royalties has a 52-week low of $17.55 and a 52-week high of $47.75. The business’s 50 day moving average price is $38.41 and its two-hundred day moving average price is $35.25.

OR Royalties (NYSE:OR) last released its earnings results on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. The company had revenue of $71.63 million for the quarter, compared to the consensus estimate of $53.85 million. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. Research analysts predict that OR Royalties will post 0.62 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Assetmark Inc. bought a new position in OR Royalties during the fourth quarter worth about $36,000. Caitlin John LLC purchased a new position in OR Royalties in the 3rd quarter valued at approximately $78,000. Allworth Financial LP raised its holdings in OR Royalties by 20.0% during the 4th quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock valued at $82,000 after acquiring an additional 384 shares during the period. Eagle Global Advisors LLC purchased a new stake in shares of OR Royalties during the third quarter worth $206,000. Finally, Merit Financial Group LLC bought a new position in shares of OR Royalties in the third quarter worth $215,000. Institutional investors own 68.52% of the company’s stock.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.